COL18A1 and neoplasm: Administration of 300 ng of recombinant α3(IV)NC1 to physiological levels in α3 chain of Type IV Collagen null mice with LLC tumors showed decrease tumor growth, the number of blood vessels and circulating endothelial cells to the wild-type baseline levels (Hamano et al. 2003; Sund et al. 2005).